Ever wonder how to find inspiration and leadership drive to transform your cutting-edge engineering idea into a viable technology powered business? In this talk, we'll delve into the fascinating journey of the Image Analysis Group (IAG), exploring the evolution of their role in using AI, cloud platform, mathematical algorithms to revolutionize drug development.
From its founder, you will hear about the history of IAG, highlighting their pioneering work in medical image analysis. You will hear about the necessity of making fast decisions, the strength needed to transform an idea into revenues, and about finding leadership power to adopt an academic technology solution to fit market demands while building a global company and leading a geographically distributed team. The founder will emphasize key takeaways from her journey as a software engineer and mathematician, which no doubt you can reflect on and apply on your own journeys as leaders.
This talk will go through the journey of the company and its leadership team. You will hear about IAG’s work, and you will see how AI can automate tasks and unveil hidden patterns invisible to the human eye, leading to faster, more informed decision-making. More importantly, you will see the real leadership skills that helped to take these algorithms to transform patient lives.
Meet the passionate individuals striving to make a difference, fueled by the desire to translate complex algorithms into tangible impact on people's lives. Hear the story, the challenges, and their unwavering commitment to pushing the boundaries of healthcare innovation.
Dr. Olga Kubassova
President @IAG, Image Analysis Group
Mathematician, PhD Computer Scientist and Entrepreneur with passion for growing businesses and actively managing innovation in life science companies, strategy and capital raising. Olga has founded her first company out of her PhD and grew it into a successful global business, Image Analysis Group. It is dedicated to improving people’s health by assisting drug development companies in getting new drugs to the market faster. Olga closely works with innovators and investors to identify other innovative approaches to clinical research, disruptive technology platforms and novel therapeutics. Olga is an active researcher and co-author of 120+ publications. She thrives on seeing cutting-edge science transform into tangible benefits for patients.
She is a scientific adviser and venture partner to several investment funds, biotechnology and pharma companies. She advices many government bodies in the UK, EU and USA on deployment capital in life sciences.
She is a founding member of 'The 2% club' to support women in leadership positions, scholar of the Royal Society of Medicine, Royal Academy of Engineering, alumni of several business leadership programs by Goldman Sachs, Oxford Said Business School, Business School of University of Leeds, alumni of Business Programme by the New York Economic Development (New York Venture Fellows), 4 time winner of the national and international 'Entrepreneur of the Year' award.